4//SEC Filing
Smith Karen L. 4
Accession 0001209191-23-006401
CIK 0001662774other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:35 PM ET
Size
5.7 KB
Accession
0001209191-23-006401
Insider Transaction Report
Form 4
Smith Karen L.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-01+225,000→ 225,000 totalExercise: $0.94Exp: 2033-01-31→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001639637
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:35 PM ET
- Size
- 5.7 KB